Lv21
170 积分 2023-12-07 加入
Deficiency of factor-inhibiting HIF creates a tumor-promoting immune microenvironment
7小时前
已完结
Vaccination as a therapeutic strategy for Nasopharyngeal carcinoma
4天前
已完结
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy
6个月前
已完结
Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer
6个月前
已完结
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
7个月前
已完结
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
9个月前
已完结
Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations
10个月前
已完结
Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IChoice-01)
10个月前
已完结
KEYNOTE-689: A Phase 3 Study of Neoadjuvant and Adjuvant Pembrolizumab Plus Standard of Care (SOC) in Resectable, Locally Advanced (LA) Head and Neck Squamous Cell Carcinoma (HNSCC)
10个月前
已完结
皖公网安备34019202002308
